$Account.OrganizationName
SafeMeds Alert System

Warning: Counterfeit versions of the medicinal product Tertensif® found in Bulgaria
The Danish Medicines Agency recently posted the following alert:

Counterfeit versions of the medicinal product Tertensif® (indapamide) 1.5 mg enteric-coated tablets have been found at pharmacies and distributors on the Bulgarian market.

The counterfeit medicinal product, Tertensif® (indapamide), 1.5 mg enteric-coated tablets, is sold in a package containing 30 enteric-coated tablets. The following is printed on the packages:
Batch number: Package number: Expiry date:
752995 02.2006 02.2008
5K9015 10.2005 10.2007

The packages are counterfeit, and thus they are neither manufactured nor marketed by the company that manufactures the original medicinal product. The outer packaging and package leaflet of the counterfeit medicinal product is different from that of the original medicinal product.

The counterfeit medicinal product has not been distributed to Denmark . However, the Danish Medicines Agency cannot rule out that private individuals may be able to buy the medicinal product in another way, for instance over the internet or by private import from a pharmacy in Bulgaria .

Persons who have used the tablets are encouraged to stop using them and possibly consult their general practitioner.

Moreover, the Danish Medicines Agency would like to encourage people who have used the counterfeit medicinal product to hand over the remains to a pharmacy.

For further information, please contact Mikkel Walmar.

About The SafeMeds Alert System

The SafeMeds Alert System is a counterfeit alert distribution service of the the Partnership for Safe Medicines--a group of organizations and individuals that have policies, procedures, or programs to protect consumers from counterfeit or contraband medicines.

Email Marketing by